Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention

Khan, Sujoy; Molica, Stefano; Allsup, David

doi:10.1002/hon.3011

Authors

Sujoy Khan

Stefano Molica

Dr David Allsup D.J.Allsup@hull.ac.uk
Senior Lecturer in Haematology and Honorary Consultant

Citation

Khan, S., Molica, S., & Allsup, D. (2022). Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention. Hematological Oncology, https://doi.org/10.1002/hon.3011

Journal Article Type	Commentary
Acceptance Date	Apr 30, 2022
Online Publication Date	May 2, 2022
Publication Date	2022
Deposit Date	May 3, 2022
Publicly Available Date	May 3, 2023
Journal	Hematological Oncology
Print ISSN	0278-0232
Electronic ISSN	1099-1069
Publisher	Wiley
Peer Reviewed	Peer Reviewed
DOI	https://doi.org/10.1002/hon.3011
Keywords	BTK inhibitors; Chronic lymphocytic leukemia; Immunoglobulin; T cell
Public URL	https://hull-repository.worktribe.com/output/3987184

Files

Accepted manuscript (102 Kb)
PDF

Copyright Statement
©2022 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder